Efficacy of a Simplified Modified Atkins Diet in Children With Refractory Epilepsy
NCT01899898 · Status: COMPLETED · Phase: PHASE2/PHASE3 · Type: INTERVENTIONAL · Enrollment: 81
Last updated 2019-01-15
Summary
One third of children with epilepsy have seizures that are medically intractable. Uncontrolled seizures pose a variety of risks to children, including higher rates of mortality, developmental delay and cognitive impairment. Epilepsy surgery is not a feasible option for most children with refractory epilepsy. The ketogenic diet and the modified Atkins diet have been shown to be effective alternative treatments in children with refractory epilepsy. However, these need parents to be educated, and understand complex instructions of weighing foods and diet preparation. Therefore, children with parents with low levels of literacy and poor socioeconomic status have not been able to benefit from these therapies. Also, the paucity of trained dieticians and limited availability of labeled foods in resource-constraint settings has made these dietary therapies even more inaccessible.
This study aimed to to develop a simple-to-administer variation of the modified Atkins diet for use in children with refractory epilepsy and to evaluate the efficacy and tolerability of this simplified modified Atkins diet in children with refractory epilepsy in a randomized controlled open-label trial.
Conditions
- Refractory Epilepsy
Interventions
- OTHER
-
Simplified Modified Atkins Diet
Modified Atkins diet with the following modifications: 1. Pictorial representation of various food items and exchange lists will be provided. 2. Instead of weights, we will provide standardized measures 3. We will calculate the amount of carbohydrates of daily readily available foods in the standardized measures 4. We will formulate recipes and diets based on locally available and culturally acceptable foods. 5. We will develop a parent instruction manual. 6. We will also develop methods for parents with low levels of literacy to maintain seizure logs. This will be done by using bars and color codes. 7. We will develop methods for parents with low levels of literacy to measure and record urine ketones. This will be done by using color codes.
- DRUG
-
Antiepileptic drugs alone
The anti-epileptic drugs will be continued alone for 3 months following which they will be offered Simplified Modified Atkins Diet
Sponsors & Collaborators
-
Lady Hardinge Medical College
lead OTHER_GOV
Principal Investigators
-
Satinder Aneja, MD · Pediatric Neurology, Department of Pediatrics, Lady Hardinge Medical College and Associated Kalawati Saran Children's Hospital
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Min Age
- 2 Years
- Max Age
- 14 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2012-09-30
- Primary Completion
- 2015-11-30
- Completion
- 2015-11-30
Countries
- India
Study Locations
More Related Trials
-
Efficacy of Modified Ketogenic Diet (Atkins) in Management of Epilepsy
NCT00188500 ·Status: UNKNOWN ·Phase: NA
-
Effect of Outpatient Classic Ketogenic Diet in Epileptic Children and Adolescent.
NCT03031028 ·Status: UNKNOWN ·Phase: PHASE2
-
Efficacy, Tolerability and Adherence of the Modified Atkins Diet on Drug-resistant Epilepsy
NCT03183076 ·Status: COMPLETED ·Phase: NA
-
Efficacy and Safety of Ketogenic Diet as Adjunctive Treatment in Adults With Refractory Epilepsy
NCT01906398 ·Status: UNKNOWN ·Phase: PHASE2
-
Comparative Study of Dietary and Immunological Management of Refractory Epilepsy in Children
NCT04542629 ·Status: UNKNOWN ·Phase: PHASE4
-
Intermittent Fasting in Refractory Epilepsy
NCT02311023 ·Status: TERMINATED ·Phase: PHASE2
-
Low Glycemic Index Diet Therapy in Children With Refractory Epilepsy
NCT01645072 ·Status: UNKNOWN ·Phase: PHASE3
-
Efficacy of Low Glycemic Index Diet Versus Classic Ketogenic Diet in Pediatric Epilepsy Treatment
NCT06703983 ·Status: COMPLETED ·Phase: NA
-
The Modified Ketogenic Diet for the Treatment of Pharmacoresistant Epilepsy in Adults
NCT03425110 ·Status: UNKNOWN
-
IF-MCT 16:8: Investigating the Influence of Intermittent Fasting With and Without MCTs in Patients With Drug-resistant Epilepsy
NCT06013761 ·Status: COMPLETED ·Phase: NA
-
Epigenetics and Gut Microbiota in Children With Epilepsy
NCT04063007 ·Status: UNKNOWN ·Phase: NA
-
Understanding the Mechanism(s) of Action on the Modified Atkins Diet for Epilepsy: Human Brain Tissues
NCT02565966 ·Status: COMPLETED ·Phase: NA
-
A Pilot Study of the Low Glycaemic Index Diet in Adults With Epilepsy
NCT03999827 ·Status: COMPLETED ·Phase: NA
-
Role of the Gut Microbiota in Pediatric Epilepsy
NCT04705298 ·Status: UNKNOWN ·Phase: PHASE4
-
Efficacy and Safety of YKP3089 in Subjects With Treatment Resistant Partial Onset Seizures
NCT01397968 ·Status: COMPLETED ·Phase: PHASE2
-
Microbiome Composition and Biomarker Discovery in Refractory Pediatric Epilepsy
NCT04311242 ·Status: WITHDRAWN
-
The Impact of Reducing Overtreatment on Quality of Life in Children With Refractory Epilepsy
NCT00647322 ·Status: UNKNOWN ·Phase: PHASE4
-
A Study of the Efficacy and Safety of Topiramate as add-on Therapy in the Treatment of Epilepsy Patients With Difficult to Treat, Partial-onset Seizures.
NCT00236691 ·Status: COMPLETED ·Phase: PHASE2
-
A Study of the Efficacy and Safety of Topiramate as add-on Therapy in the Treatment of Epilepsy Patients With Difficult to Treat, Partial-onset Seizures.
NCT00236873 ·Status: COMPLETED ·Phase: PHASE2
-
Energy Expenditure and Quality of Life in Epilepsy
NCT04546711 ·Status: WITHDRAWN
-
Sodium-Glucose Cotransporter-2 Inhibitors: A Potential Novel Treatment for Epilepsy
NCT05512130 ·Status: UNKNOWN ·Phase: EARLY_PHASE1
-
Duration of Anti-convulsant Therapy for Acute Symptomatic Seizure in Acute Encephalitis Syndrome
NCT03181945 ·Status: UNKNOWN ·Phase: NA
-
Thalidomide Low Threshold in Epilepsy
NCT01061866 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
A Study of the Effectiveness and Safety of Topiramate Monotherapy in Patients With Recently Diagnosed Partial-Onset Seizure
NCT00230698 ·Status: COMPLETED ·Phase: PHASE3
-
Pharmacokinetics of Anti-epileptic Drugs in Obese Children
NCT02993861 ·Status: COMPLETED